Russ R. is currently the Chief Operating Officer at StrongHolt Therapeutics, where they focus on advancing AAV-based gene therapy for Duchenne muscular dystrophy. Their extensive background includes roles as a cardiothoracic surgeon in various healthcare organizations, including UCHealth and Timpanogos Regional Hospital, alongside serving as a Scientific Advisor for Xenter and GlycoMira Therapeutics. Russ has also held leadership positions in medical device development and regenerative medicine, contributing to successful clinical trials and innovative therapies. They received education from institutions such as Columbia University and Drexel University, specializing in interventional cardiology, gene therapy, and cardiothoracic surgery.
This person is not in the org chart
This person is not in any teams
This person is not in any offices